A comparative analysis of the efficacy of phenytoin and Betadine on healing of diabetic foot ulcer

Phase 3

• Conditions: Diabetic foot ulcer.; Ulcer of lower limb, not elsewhere classified

• Registration Number: IRCT20181105041563N5
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Physician and patient satisfaction
Patient alertness (GCS = 15)
Age over 18
do not allergic to to iodine and phenytoin
No pregnancy
Lack of hepatic impairment and renal failure (creatinine level below 2), cancer and osteomyelitis
Do not use immunosuppressive and corticosteroid during the last month
No smoking
Controlled blood sugar
Grade I and II foot ulcers according to Meggit-Wagner

Exclusion Criteria

Unwillingness to co-operate with a patient or physician
Grade III, IV, V foot ulcers according to Meggit-Wagner
Amputation
Death

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ength and width of diabetic foot ulcer. Timepoint: One, two, three, four, six, eight, ten, and twelve weeks after starting treatment and at the end of the study. Method of measurement: ruler.;Grade of diabetic foot ulcer. Timepoint: One, two, three, four, six, eight, ten, and twelve weeks after starting treatment and at the end of the study. Method of measurement: Wagner ,Pedis and Beta johnson scale.;Infection of diabetic foot ulcer. Timepoint: One, two, three, four, six, eight, ten, and twelve weeks after starting treatment and at the end of the study. Method of measurement: Pedis scale.